Catalyst Pharmaceutical
CPRX
CPRX
255 hedge funds and large institutions have $949M invested in Catalyst Pharmaceutical in 2023 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 79 increasing their positions, 91 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
2.17% less ownership
Funds ownership: 77.68% → 75.51% (-2.2%)
13% less repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 91
14% less capital invested
Capital invested by funds: $1.11B → $949M (-$159M)
Holders
255
Holding in Top 10
4
Calls
$1.42M
Puts
$694K
Top Buyers
| 1 | +$14.1M | |
| 2 | +$6.68M | |
| 3 | +$5.91M | |
| 4 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$4.09M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$3.9M |
Top Sellers
| 1 | -$22M | |
| 2 | -$11.2M | |
| 3 | -$9.99M | |
| 4 |
Two Sigma Advisers
New York
|
-$8.51M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$6M |